Wnt Signaling in Ewing Sarcoma, Osteosarcoma, and Malignant Peripheral Nerve Sheath Tumors

被引:36
|
作者
Pridgeon, Matthew G. [1 ,2 ,3 ]
Grohar, Patrick J. [2 ,3 ,4 ,5 ]
Steensma, Matthew R. [2 ,3 ,5 ,6 ]
Williams, Bart O. [5 ]
机构
[1] Grand Rapids Med Educ Partners, Grand Rapids, MI USA
[2] Spectrum Hlth Syst, Spectrum Hlth Canc Ctr, Grand Rapids, MI USA
[3] Helen De Vos Childrens Hosp, Grand Rapids, MI USA
[4] Michigan State Univ, Dept Pediat, Grand Rapids, MI USA
[5] Van Andel Res Inst, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA
[6] Michigan State Univ, Coll Human Med, Dept Surg, Grand Rapids, MI USA
关键词
Wnt; beta-catenin; Ewing sarcoma; Neurofibromatosis Type 1; Osteosarcoma; Malignant peripheral nerve sheath tumors; WNT/BETA-CATENIN; BETA-CATENIN; DRIVES PROLIFERATION; INHIBITORY FACTOR-1; GENOMIC LANDSCAPE; GENE-EXPRESSION; PATHWAY; CELLS; ACTIVATION; PROMOTES;
D O I
10.1007/s11914-017-0377-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of Review Wnt signaling plays a central role in development and homeostasis, and its dysregulation is a common event in many types of human cancer. Here we explore in detail the contributions of Wnt signaling to the initiation and maintenance of three types of saroma: Ewing sarcoma, osteosarcoma, and malignant peripheral nerve sheath tumors. This review provides an overview of the Wnt signaling pathway and explores in detail the current knowledge about its role in the initiation or maintenance of three tumor types: Ewing sarcoma, osteosarcoma, and malignant peripheral nerve sheath tumors. Recent Findings Recent work has assessed the role(s) of Wnt signaling within these cell types. This review provides an overview of the mechanistic insights that have been gained from a number of recent studies to set the foundation for potential therapeutic applications. Summary Wnt signaling has emerged as a potentially critical pathway in maintaining the growth of these types of tumors. Given the fact that many new inhibitors of the pathway have recently or will soon enter Phase 1 clinical trials, it is likely that assessment of their activity in these tumor types will occur in human patients.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 50 条
  • [41] Hyaluronan expression as a significant prognostic factor in patients with malignant peripheral nerve sheath tumors
    Kunihiro Ikuta
    Hiroshi Urakawa
    Eiji Kozawa
    Eisuke Arai
    Lisheng Zhuo
    Naohisa Futamura
    Shunsuke Hamada
    Koji Kimata
    Naoki Ishiguro
    Yoshihiro Nishida
    Clinical & Experimental Metastasis, 2014, 31 : 715 - 725
  • [42] PhaseIIclinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors
    Nishida, Yoshihiro
    Urakawa, Hiroshi
    Nakayama, Robert
    Kobayashi, Eisuke
    Ozaki, Toshifumi
    Ae, Keisuke
    Matsumoto, Yoshihiro
    Tsuchiya, Hiroyuki
    Goto, Takahiro
    Hiraga, Hiroaki
    Naka, Norifumi
    Takahashi, Shunji
    Ando, Yuichi
    Ando, Masahiko
    Kuwatsuka, Yachiyo
    Hamada, Shunsuke
    Ueda, Takafumi
    Kawai, Akira
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (01) : 140 - 149
  • [43] Investigation of Ultrasound Parameters for the Differential Diagnosis of Malignant and Benign Peripheral Nerve Sheath Tumors
    Jin, Zhenzhen
    Zhao, Kaiping
    Guo, Wen
    Wang, Dandan
    Deng, Yukun
    Chen, Tao
    JOURNAL OF ULTRASOUND IN MEDICINE, 2022, 41 (12) : 3091 - 3101
  • [44] Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II Trials
    Akshintala, Srivandana
    Mallory, Nicole C.
    Lu, Yao
    Ballman, Karla V.
    Schuetze, Scott M.
    Chugh, Rashmi
    Maki, Robert G.
    Reinke, Denise K.
    Widemann, Brigitte C.
    Kim, AeRang
    ONCOLOGIST, 2023, 28 (05) : 453 - 459
  • [45] PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor
    Perrone, Federica
    Da Riva, Luca
    Orsenigo, Marta
    Losa, Marco
    Jocolle, Genny
    Millefanti, Clara
    Pastore, Elisa
    Gronchi, Alessandro
    Pierotti, Marco Alessandro
    Pilotti, Silvana
    NEURO-ONCOLOGY, 2009, 11 (06) : 725 - 736
  • [46] STAT3 and HIF1α Signaling Drives Oncogenic Cellular Phenotypes in Malignant Peripheral Nerve Sheath Tumors
    Rad, Ellie
    Dodd, Kayleigh
    Thomas, Laura
    Upadhyaya, Meena
    Tee, Andrew
    MOLECULAR CANCER RESEARCH, 2015, 13 (07) : 1149 - 1160
  • [47] The Ewing Sarcoma Secretome and Its Response to Activation of Wnt/beta-catenin Signaling
    Hawkins, Allegra G.
    Basrur, Venkatesha
    Leprevost, Felipe da Veiga
    Pedersen, Elisabeth
    Sperring, Colin
    Nesvizhskii, Alexey I.
    Lawlor, Elizabeth R.
    MOLECULAR & CELLULAR PROTEOMICS, 2018, 17 (05) : 901 - 912
  • [48] TCF4 Mediates the Maintenance of Neuropathic Pain Through Wnt/β-Catenin Signaling Following Peripheral Nerve Injury in Rats
    Xu, Zhongling
    Chen, Yan
    Yu, Jiang
    Yin, Dekun
    Liu, Chun
    Chen, Xiangdong
    Zhang, Dongmei
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2015, 56 (02) : 397 - 408
  • [49] Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumors in Bronchus
    Chen, Jun
    Yuan, Tao
    Liu, Xiao
    Hua, Bei
    Dong, Chenfeng
    Liu, Yawu
    Quan, Guanmin
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 357 (01) : 75 - 80
  • [50] Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Related Tumors
    Tsokos, Maria
    Alaggio, Rita D.
    Dehner, Louis P.
    Dickman, Paul S.
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2012, 15 : 108 - 126